Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Shares Outstanding (Diluted Average) (2019 - 2025)

Bioadaptives' Shares Outstanding (Diluted Average) history spans 4 years, with the latest figure at $10.1 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $10.1 million for Q4 2025, up 22.61% from a year ago — trailing twelve months through Dec 2025 was $10.1 million (up 22.61% YoY), and the annual figure for FY2025 was $10.1 million, up 22.61%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $10.1 million at Bioadaptives, up from $9.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $10.1 million in Q4 2025 to a low of $3.7 million in Q2 2024.